| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 27-Dec-08 | 28-Jun-08 | | Total Revenue | 110,516 | 52,076 | 123,532 | 180,119 | | Cost of Revenue | 63,315 | 32,407 | 72,914 | 143,380 | | | Gross Profit | 47,201 | 19,669 | 50,618 | 36,739 | | | Operating Expenses | | Research Development | 12,561 | 12,264 | 14,532 | 15,440 | | Selling General and Administrative | 188,967 | 21,887 | 25,151 | 23,099 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,040 | (14,482) | 10,935 | (1,800) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 84 | 75 | 1,739 | 968 | | Earnings Before Interest And Taxes | 8,124 | (14,407) | 12,674 | (832) | | Interest Expense | 620 | 607 | 872 | 850 | | Income Before Tax | 7,504 | (15,014) | 11,802 | (1,682) | | Income Tax Expense | 285 | (1,156) | 4,769 | 115 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,219 | (13,858) | 7,033 | (1,797) | | | Non-recurring Events | | Discontinued Operations | (716) |
-
| 9,329 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,503 | (13,858) | 16,362 | (1,797) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,503 | ($13,858) | $16,362 | ($1,797) |
|
0.31% Nasdaq 0.00%
Income Statement
